TERUMO CORPORATION
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance 2025-10-24 20:00
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies 2025-10-22 22:39
Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System 2025-05-28 01:40
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer 2025-04-17 03:00
Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US 2025-04-17 01:10
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care 2024-12-10 21:00
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter 2024-12-03 21:00
Terumo Establishes Corporate Venture Capital "Terumo Ventures" 2024-08-06 09:00
FDA Clears the Individualized Nomogram for Rika Plasma Donation System 2024-05-09 20:00
Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use 2023-08-01 20:30
Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA 2023-02-17 03:48
New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography 2022-11-01 20:00
Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan 2022-05-16 15:19
Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing 2022-03-30 15:00
Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture 2022-03-01 09:00
Terumo and Corazon Sign Collaboration and Co-Marketing Agreement 2022-02-25 22:00
Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A 2022-01-12 03:40
Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings 2021-11-17 16:00
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe 2021-11-17 00:00
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare 2021-09-17 15:30
1 2